Inspire Investing’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-131,892
| Closed | -$401K | – | 891 |
|
|
2024
Q4 | $401K | Buy |
131,892
+53,837
| +69% | +$164K | 0.04% | 546 |
|
|
2024
Q3 | $405K | Sell |
78,055
-61,024
| -44% | -$317K | 0.04% | 746 |
|
|
2024
Q2 | $357K | Buy |
139,079
+65,919
| +90% | +$169K | 0.04% | 374 |
|
|
2024
Q1 | $360K | Buy |
73,160
+29,645
| +68% | +$146K | 0.04% | 488 |
|
|
2023
Q4 | $382K | Buy |
43,515
+16,923
| +64% | +$149K | 0.04% | 683 |
|
|
2023
Q3 | $305K | Buy |
26,592
+14,151
| +114% | +$162K | 0.04% | 744 |
|
|
2023
Q2 | $315K | Buy |
12,441
+3,977
| +47% | +$101K | 0.04% | 502 |
|
|
2023
Q1 | $273K | Sell |
8,464
-4,334
| -34% | -$140K | 0.03% | 647 |
|
|
2022
Q4 | $236K | Buy |
12,798
+5,109
| +66% | +$94.3K | 0.03% | 452 |
|
|
2022
Q3 | $208K | Sell |
7,689
-7,851
| -51% | -$212K | 0.03% | 421 |
|
|
2022
Q2 | $215K | Buy |
15,540
+3,316
| +27% | +$45.9K | 0.03% | 361 |
|
|
2022
Q1 | $238K | Sell |
12,224
-3,183
| -21% | -$62K | 0.03% | 405 |
|
|
2021
Q4 | $251K | Buy |
+15,407
| New | +$251K | 0.03% | 421 |
|